BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 16494977)

  • 1. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.
    Liu SJ; Leng CH; Lien SP; Chi HY; Huang CY; Lin CL; Lian WC; Chen CJ; Hsieh SL; Chong P
    Vaccine; 2006 Apr; 24(16):3100-8. PubMed ID: 16494977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP; Lin JY; Jan JT; Leng CH; Chu CC; Yang YC; Chen SL
    Biochem Biophys Res Commun; 2006 May; 344(1):63-71. PubMed ID: 16630549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
    He Y; Zhou Y; Wu H; Luo B; Chen J; Li W; Jiang S
    J Immunol; 2004 Sep; 173(6):4050-7. PubMed ID: 15356154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus.
    He Y; Zhou Y; Wu H; Kou Z; Liu S; Jiang S
    J Clin Microbiol; 2004 Nov; 42(11):5309-14. PubMed ID: 15528730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice.
    Zheng N; Xia R; Yang C; Yin B; Li Y; Duan C; Liang L; Guo H; Xie Q
    Vaccine; 2009 Aug; 27(36):5001-7. PubMed ID: 19523911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
    Kumar S; Jones TR; Oakley MS; Zheng H; Kuppusamy SP; Taye A; Krieg AM; Stowers AW; Kaslow DC; Hoffman SL
    Infect Immun; 2004 Feb; 72(2):949-57. PubMed ID: 14742540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
    Zhao J; Huang Q; Wang W; Zhang Y; Lv P; Gao XM
    J Virol; 2007 Jun; 81(11):6079-88. PubMed ID: 17392374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Chan C; He Y; Jiang S; Wu C; Jin DY; Yuen KY; Zhou Y; Zheng BJ
    Vaccine; 2008 Mar; 26(13):1644-51. PubMed ID: 18289745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination.
    Pei H; Liu J; Cheng Y; Sun C; Wang C; Lu Y; Ding J; Zhou J; Xiang H
    Appl Microbiol Biotechnol; 2005 Aug; 68(2):220-7. PubMed ID: 15660214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.
    Peng H; Yang LT; Wang LY; Li J; Huang J; Lu ZQ; Koup RA; Bailer RT; Wu CY
    Virology; 2006 Aug; 351(2):466-75. PubMed ID: 16690096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
    Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
    Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
    J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.
    Dutta NK; Mazumdar K; Lee BH; Baek MW; Kim DJ; Na YR; Park SH; Lee HK; Kariwa H; Mai le Q; Park JH
    Immunol Lett; 2008 Jun; 118(1):65-71. PubMed ID: 18440652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope.
    Cheung YK; Cheng SC; Sin FW; Chan KT; Xie Y
    Vaccine; 2007 Aug; 25(32):6070-7. PubMed ID: 17629360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens.
    Gupta V; Tabiin TM; Sun K; Chandrasekaran A; Anwar A; Yang K; Chikhlikar P; Salmon J; Brusic V; Marques ET; Kellathur SN; August TJ
    Virology; 2006 Mar; 347(1):127-39. PubMed ID: 16387339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
    Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
    Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
    Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
    J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.